Miller VA - Search Results

1

Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.

Sirotnak FM, Zakowski MF, Miller VA, Scher HI, Kris MG. Sirotnak FM, et al. Among authors: miller va. Clin Cancer Res. 2000 Dec;6(12):4885-92. Clin Cancer Res. 2000. PMID: 11156248

2

Primary squamous cell carcinoma of the prostate after radiation seed implantation for adenocarcinoma.

Miller VA, Reuter V, Scher HI. Miller VA, et al. Urology. 1995 Jul;46(1):111-3. doi: 10.1016/S0090-4295(99)80174-5. Urology. 1995. PMID: 7541581

3

Paclitaxel (Taxol) and docetaxel (Taxotere): active chemotherapeutic agents in lung cancer.

Francis PA, Kris MG, Rigas JR, Grant SC, Miller VA. Francis PA, et al. Among authors: miller va. Lung Cancer. 1995 Apr;12 Suppl 1:S163-72. doi: 10.1016/0169-5002(95)00432-z. Lung Cancer. 1995. PMID: 7551925 Free article. Review.

4

Effectiveness and toxicity of preoperative therapy in stage IIIA non-small cell lung cancer including the Memorial Sloan-Kettering experience with induction MVP in patients with bulky mediastinal lymph node metastases (Clinical N2).

Kris MG, Pisters KM, Ginsberg RJ, Rigas JR, Miller VA, Grant SC, Gralla RJ, Heelan RT, Martini N. Kris MG, et al. Among authors: miller va. Lung Cancer. 1995 Apr;12 Suppl 1:S47-57. doi: 10.1016/0169-5002(95)00420-6. Lung Cancer. 1995. PMID: 7551934 Free article. Review.

5

Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy.

Miller VA, Rigas JR, Pisters KM, Grant SC, Pfister DG, Heelan RT, Kris MG. Miller VA, et al. Am J Clin Oncol. 1995 Aug;18(4):303-6. doi: 10.1097/00000421-199508000-00007. Am J Clin Oncol. 1995. PMID: 7625371 Clinical Trial.

6

New chemotherapeutic agents for non-small cell lung cancer.

Miller VA, Rigas JR, Grant SC, Pisters KM, Kris MG. Miller VA, et al. Chest. 1995 Jun;107(6 Suppl):306S-311S. doi: 10.1378/chest.107.6_supplement.306s. Chest. 1995. PMID: 7781411 Review.

7

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer.

Miller VA, Rigas JR, Francis PA, Grant SC, Pisters KM, Venkatraman ES, Woolley K, Heelan RT, Kris MG. Miller VA, et al. Cancer. 1995 Feb 15;75(4):968-72. doi: 10.1002/1097-0142(19950215)75:4<968::aid-cncr2820750411>3.0.co;2-y. Cancer. 1995. PMID: 7842417 Clinical Trial.

8

Clinical and pharmacology study of chloroquinoxaline sulfonamide given on a weekly schedule.

Rigas JR, Francis PA, Miller VA, Tong WP, Roistacher N, Kris MG, Orazem JP, Young CW, Warrell RP Jr. Rigas JR, et al. Among authors: miller va. Cancer Chemother Pharmacol. 1995;35(6):483-8. doi: 10.1007/BF00686832. Cancer Chemother Pharmacol. 1995. PMID: 7882456 Clinical Trial.

9

Modulation of all-trans retinoic acid pharmacokinetics by liarozole.

Miller VA, Rigas JR, Muindi JR, Tong WP, Venkatraman E, Kris MG, Warrell RP Jr. Miller VA, et al. Cancer Chemother Pharmacol. 1994;34(6):522-6. doi: 10.1007/BF00685665. Cancer Chemother Pharmacol. 1994. PMID: 7923564 Clinical Trial.

10

Metabolic phenotypes of retinoic acid and the risk of lung cancer.

Rigas JR, Miller VA, Zhang ZF, Klimstra DS, Tong WP, Kris MG, Warrell RP Jr. Rigas JR, et al. Among authors: miller va. Cancer Res. 1996 Jun 15;56(12):2692-6. Cancer Res. 1996. PMID: 8665495

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

485 results

Search Page

Filters